Management of sepsis during MARS treatment in acute on chronic liver failure. (Q38463461)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Management of sepsis during MARS treatment in acute on chronic liver failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Massimo Rossi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

G Novelli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

V Morabito

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

F Pugliese

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

G Ferretti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

S Novelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

S Ianni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

P B Berloco

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

1085-1090

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

Liver transplantation for fulminant hepatic failure

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Role of cytokines in the pathophysiology of acute-on-chronic liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Endotoxemia contributes to the immune paralysis in patients with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Sepsis: a new hypothesis for pathogenesis of the disease process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Endotoxin tolerance: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Patients with acute on chronic liver failure display "sepsis-like" immune paralysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Endotoxin apheresis for sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Multi-scale analysis of the toraymyxin adsorption cartridge. Part II: computational fluid-dynamic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Strategies for the treatment of sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.01.150

10.1016/J.TRANSPROCEED.2011.01.150

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21620059%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference